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Abstract
Background: Scientists from less-developed countries (LDC) perceive that it is difficult to publish in international
journals from their countries. This online survey was conducted with the primary aim of determining the opinion
of corresponding authors of published papers in international Pharmacology journals regarding the difficulties in
publications and their possible solutions.
Methods: The titles of all Pharmacology journals were retrieved from Pubmed. 131 journals were included in
study. The latest issue of all journals was reviewed thoroughly. An online survey was conducted from the
corresponding authors of the published papers who belonged to LDC.
Results: 584 out 1919 papers (30.4%) originated from the LDC. 332 responses (response rate; 64.5%) were received
from the authors. Approximately 50% the papers from LDC were published in journals with impact factor of less
than 2. A weak negative correlation (r = -0.236) was observed between journal impact factor and the percentage
of publications emanating from LDC. A significant majority of the corresponding authors (n = 254; 76.5%)
perceived that it is difficult to publish in good quality journals from their countries. According to their opinion,
biased attitude of editors and reviewers (64.8%) is the most important reason followed by the poor writing skills of
the scientists from LDC (52.8%). The authors thought that well-written manuscript (76.1%), improvement in the
quality of research (69.9%) and multidisciplinary research (42.9%) are important determinants that may improve the
chances of publications.
Conclusions: The LDC are underrepresented in publications in Pharmacology journals. The corresponding authors
of the published articles think that biased attitude of the editors as well as the reviewers of international journals
and the poor writing skills of scientists are the major factors underlying the non-acceptance of their results. They
also think that the improvement in the writing skills and quality of research will increase the chances of
acceptance of their works in international journals.
Background
Publishing in prominent scientific journals provides bet-
ter visibility and impact of research results at individual
as well as institutional and national level. Scientists are
under continuous pressure to publish in international
journals in order to obtain rewards and promotions [1,2].
This also applies to scientists residing in less-developed
(middle and low income) countries. Scientists from less-
developed countries (LDC) perceive that it is difficult to
get publications in reputable biomedical journals and the
results of the studies in the fields of epidemiology [3],
psychiatry [4], and cardiology [5] confirm the underre-
presentation of LDC authors in the respective interna-
tional journals. The conclusion of one survey indicates
that researchers from LDC believe that the editorial bias
against their works based on geographical location is a
major reason for underrepresentation in publications [6].
In addition to quantity, the quality is increasingly recog-
nized as a critical aspect while evaluating research. In the
1970s, some objective parameters were suggested as a
means to evaluate quality of research [7,8]. Among these
parameters, the impact factor (IF) of the journal is widely
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research [9,10]. The idea of IF was first coined by Garfield
in 1955 [11]. It is an instrument for the assessment of
quality of the journal monitored periodically by Thomson
Scientific (formerly International Scientific Institute-ISI),
Philadelphia [12]. Although, there are several criticisms
regarding the usage of IF as a tool to measure the quality
of publication [13,14], it is still a very simple, convenient
and quick indicator for assessing the impact and quality of
research [15]. Furthermore, this parameter is given a lot of
weightage for recruitments, funding, promotions and
rewards [15].
To date, no study has documented the opinion of scien-
tists from LDC regarding the difficulties in publishing
their work. Therefore, this online survey was conducted
with the primary aim of determining the opinion of corre-
sponding authors of published papers in international
Pharmacology journals regarding the perceived difficulties
in publishing their findings and the possible solutions. The
secondary aim of the study was to determine the number
of publications emanating from LDC in Pharmacology
journals.
Methods
Identification and inclusion of journals
Pubmed was accessed in the first week of June 2010.
Medline journals were searched by the broad subject
term “Pharmacology”, while related subject terms were
not taken into account. The search generated 297 titles
of Pharmacology journals which were indexed by
Pubmed. After a thorough scrutiny, 131 journals were
included in study (Table 1). The rest were excluded due
to one of the following reasons. The journal was no
longer being published with the same name as was
retrieved from search; this included change of name or
the merger with some other journal, or the last publica-
tion was more than a year old. Non-English language
journals were also excluded from the study.
Data collection
The latest issue of each of the selected 131 Pharmacology
journals was reviewed thoroughly. For this, the web sites
of the journals were accessed to check for the latest print
issue. For online only journals, the latest issue was taken
into account. The web sites of certain journals were non-
functional; in those cases the abstracts of the latest issues
were retrieved from Pubmed. The addresses of corre-
sponding authors of original articles including short com-
munications, and review papers were obtained. Editorials,
commentaries and correspondences were excluded. The
articles were selected in which the corresponding authors
belonged to countries other than the high income OECD
countries. At the time of designing the study (April
2010), 27 countries were mentioned as members of the
OECD on the Organisation’s web site and accordingly
these countries were excluded from the study. A data
base was created in Microsoft word for those articles
published from non-OECD countries. The data base con-
tained abstract with full citation data, names of the
authors with affiliation and e mail addresses of corre-
sponding authors (if available). A review of the latest
issues of journals was started from the last week of June
2010 and was completed in the middle of September.
A separate data base was created in Microsoft Excel in
which the information about the volume and issue of the
journals (which were reviewed), date of publication, jour-
nal IF for 2009, total number of articles published in that
particular issue, number of papers from non-OECD
countries and the country of corresponding authors were
entered. All the corresponding authors whose e mail
addresses were available were contacted through e mail.
A structured questionnaire was sent to them that
contained questions asking their opinion regarding the
publications from the LDC in Pharmacology journals
(Appendix I). In a few instances, there was more than
one paper from the same corresponding author in one
issue; in that case separate e mails were sent to them for
each paper. In some papers, there were more than one
corresponding authors; in that case, all corresponding
authors were contacted. The first response for that parti-
cular publication was entered for analysis. For non-
responders, the reminders (up to three) were sent after
two weeks following the preceding e mail. Figure 1
depicts the flow of study.
Statistical analysis
All the filled questionnaires from the corresponding
authors were edited, coded and the responses were
entered. As per the objectives of the study, the data pre-
sented are mainly descriptive. Pearson Correlation Coef-
ficient was used to observe the direction and strength of
relationship between the journal IF and percentage of
publications emanating from the LDC. A scatter plot
was also made to demonstrate this relationship.
Results
As mentioned in the Methods, after exclusion, 131
Pharmacology journals were reviewed (Table 1). The
total number of papers in all journals was 1919. Out of
these, 584 (30.4%) originated from the non-OECD
(hereafter referred as less-developed) countries. E mail
addresses of 69 corresponding authors could not be
retrieved. Corresponding authors of the remaining 515
papers were sent an e mail with an attached question-
naire. E mail could not be delivered to nine authors
and five authors declined to participate. At the end of
the study, 332 responses (response rate; 64.5%) were
received (Figure 1).
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Page 2 of 8Table 1 Journals included in the survey
AAPS J Drug Discov Today J Pharmacol Sci
AAPS PharmSciTech Drug Metab Dispos J Pharm Pharm Sci
Acta Pharmacologica Sinica Drug Metab Pharmacokinet J Physiol Pharmacol
Adv Drug Delivery Rev Drug Metab Lett J Vet Pharmacol Ther
Adv Pharmacol Drug Metab Rev Magnes Res
Aliment Pharmacol Ther Drug News Perspect Mar Drugs
Ann Pharmacother Drug Test Anal Med Res Rev
Arzneimittel-Forschung Drugs Methods Find Exp Clin Pharmacol
Assay Drug Dev Techn Eur J Clin Pharmacol Mol Diagn Ther
Auton Autacoid Pharmacol Eur J Pharm Sci Mol Interv
Basic Clin Pharmacol Toxicol Eur J Pharm Biopharm Mol Pharm
Behav Pharmacol Eur J Pharmacol Mol Pharmacol
Biochem Pharmacol Eur Rev Med Pharmacol Sci Nat Prod Commun
Biol Pharm Bull Expert Opin Drug Deliv Nat Rev Drug Discov
Biopharm Drug Dispos Expert Opin Drug Saf Naunyn-Schmiedeberg’s Arch Pharmacol
Brit J Clin Pharmacol Expert Opin Pharmacother Neuropharmacology
Brit J Pharmacol Expert Rev Pharmacoeconomics Out Res Pak J Pharm Sci
Can J Physiol Pharmacol Food Drug Law J PDA J Pharm Sci Technol
Cardiovasc Hematol Agents Med Chem Fund Clin Pharmacol Pharm Dev Technol
Cell Physiol Biochem IDrugs Pharm Res
Cent Nerv Syst Agents Med Chem Immunopharmacol Immunotoxicol Pharm Stat
Chem Pharm Bull Indian J Physiol Pharmacol PharmacoEconomics
Chem Biol Drug Des Inflammopharmacology Pharmacogenet Genomics
Chem-Biol Interact Int Immunopharmacol Pharmacogenomics
ChemMedChem Int J Clin Pharmacol Ther Pharmacogenomics J
Clin Drug Invest Int J Immunopathol Pharmacol Pharmacol Rep
Clin Exp Pharmacol Physiol Int J Pharm Pharmacol Research
Clin Pharmacokinet Invest New Drugs Pharmacol Reviews
Clin Pharmacol Ther J Basic Clin Physiol Pharmacol Pharmacology
CNS Drugs J Biopharm Stat Pharmacol Ther
Comp Biochem Physiol C J Cardiovasc Pharmacol Pharmacol Biochem Behav
Curr Clin Pharmacol J Cardiovasc Pharmacol Ther Proc West Pharmacol Soc
Curr Comput Aided Drug Des J Clin Pharmacol Prog Drug Res
Curr Drug Deliv J Control Release Prog Med Chem
Curr Drug Discov Technol J Drug Target Pulm Pharmacol Ther
Curr Drug Saf J Ethnopharmacol Recent Pat Drug Deliv Formul
Curr Mol Pharmacol J Nat Prod Recent Pat Inflamm Allergy Drug Discov
Curr Opin Drug Discov Dev J Neuroimmune Pharmacol Regul Toxicol Pharmacol
Curr Opin Pharmacol J Ocul Pharmacol Ther Skin Pharmacol Physiol
Curr Pharm Biotechnol J Pharm Biomed Anal Toxicol Appl Pharmacol
Curr Pharm Des J Pharm Pharmacol Trends Pharmacol Sci
Curr Vasc Pharmacol J Pharm Sci Value Health
Drug Deliv J Pharmacol Exp Ther Vasc Pharmacol
Drug Des Dev Ther J Pharmacol Toxicol Methods
The titles of the journals were retrieved from Pubmed using key word “Pharmacology”. After exclusion as mentioned in “Methods”, all journals mentioned in the
Table were analyzed in the study.
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cology journals and those of the authors are presented in
Table 2. Approximately half of the papers from LDC were
published in journals with an IF of less than 2. Only 7.0%
of all the papers were published in journals with an IF of
more than 4. As mentioned by the corresponding authors,
47.9% of those publications had been rejected previously
by other journals. The average number of times, the cur-
rently published papers were earlier rejected was 1.57
(range; 0-4). Nearly 8% of the publications contained at
least one coauthor from countries belonging to OECD. An
overwhelming majority of the corresponding authors were
faculty (86.2%) followed by students (6.6%).
The journal IF for year 2009 was noted. Figure 2 illus-
trates the correlation between the journal IF and the pub-
lication rate from the LDC. A weak negative correlation
(r = -0.236) was observed between the journal IF and the
percentage of publications emanating from LDC. This
indicates that as the IF of the journal increases the per-
centage of publications from LDC decreases.
Table 3 shows the country affiliation of corresponding
authors. Forty-three countries were represented in the
papers published in Pharmacology journals. China had
the highest number of publications (28.6%) followed by
India (19.7%) and Brazil (6.3%).
A significant majority of the corresponding authors
(n = 254; 76.5%) perceived that it is difficult to publish
in good quality journals from their countries. These
authors who perceived difficulties in publication from
their countries were further asked to identify the
reasons underlying the perceived difficulties in publica-
tion. 250 authors responded to this question and
according to their opinion, biased attitude of editors
and reviewers (64.8%) is the most important reason,
followed by poor writing skills of the scientists (52.8%)
from LDC (Table 4).
All corresponding authors were also asked to identify
the factors which might enhance the chances of accep-
tance of papers submitted by scientists from LDC. As
shown in Table 5, according to their opinion, well-writ-
ten manuscript (76.1%), improvement in the quality of
research (69.9%) and multidisciplinary research (42.9%)
are important determinants that may improve the
chances for publications.
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Q 
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Figure 1 Flow chart of the study.
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Page 4 of 8Discussion
This study has documented for the first time the repre-
sentation of papers from LDC in Pharmacology journals
and the opinion of the corresponding authors from
these countries regarding the difficulties in publishing
their studies.
The classification of the countries into developed and
less-developed was based upon the membership of
OECD. Those with OECD membership were labeled as
developed and others as less-developed. The rationale
for following this classification is that as OECD mem-
bership is restricted to high income countries as defined
by the World Bank [16] which have an established
democratic government set up [17]. However, it should
be noted that at the time of the study design, the mem-
bership of OECD was only 27, which has expanded up
to 34 countries at the time of writing the manuscript.
The data obtained from the authors of 7 new OECD
members is included with other LDC.
According to US Census Bureau’s International Data
B a s e ,O E C Dc o u n t r i e sc o m p r i s eo n l y1 3 %o ft h ew o r l d
population in the year 2010 [18]. However, this part of
the world contributed more than two thirds of the total
number of publications in Pharmacology journals com-
pared to around 30% by the LDC. There were four jour-
nals; one each from China, India, Pakistan and Poland
which published articles mainly from their own countries.
Table 2 Characteristics of papers and their corresponding authors
Characteristics n (%)
N = 584*
Characteristics n (%)
N = 332*
Journal Impact Factor Paper rejected from other journal(s) 159 (47.9)
<1.00 165 (28.2)
1.00-<2.00 118 (20.2)
2.00-<3.00 186 (31.9)
3-<4 73 (12.5)
≥4 42 (7.2)
Number of authors Corresponding authors
1 12 (2.1)
2-4 242 (41.4) Faculty 286 (86.2)
5-7 226 (38.7) Students 22 (6.6)
8-10 81 (13.9) Industry 14 (4.2)
>10 23 (3.9) person 10 (3.0)
Others
Co-author(s) from developed country 46 (7.9)
*The number of responses varies because the source of data as mentioned above in the Table caption is different.
The table shows the characteristics of the publications and the corresponding authors. The data on the number of authors and the presence of coauthor from
developed countries was obtained from the papers themselves. The data on previous rejection(s), and position of corresponding authors were obtained from the
authors themselves via e mail.
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Figure 2 Correlation between the journal impact factor and
the publication rate. The scatter plot shows a weak negative
correlation between the impact factor of the journal and
publications (in percentage) from the less-developed countries. The
trendline shows that as the impact factor of the journal increases
the publication rate from the less-developed countries decreases.
Table 3 Major countries contributing to publications
from developing countries
Country Number of publications (% of total)
China 167 (28.6)
India 115 (19.7)
Brazil 37 (6.3)
Korea 36 (6.2)
Mexico 35 (6.0)
Poland 30 (5.1)
Iran 20 (3.4)
Turkey 15 (2.6)
Argentina 14 (2.4)
Others (34 countries) 115 (19.7)
Total 584 (100.00)
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from LDC. If we exclude these four journals from the
analysis, the actual representation in international jour-
nals drops to 26.7%. Previously, publication rates of 4.8
[19] and 6.0% [4] in psychiatry, 5.0% in tropical medicine
[20], 6.5% in internal medicine [21], 5.5% in ophthalmol-
ogy [22], 0.3% in anesthesiology [23] and very few in sur-
gery [24] journals from LDC have been reported. These
figures are grossly different from those presented in this
study. However, there is a basic difference in the metho-
dology of above studies and the current one. Previous
reports have analysed only those papers that were pub-
lished in leading journals with high IF in their respective
fields. However, our study has analysed all Medline-
indexed Pharmacology journals. Since we found that the
publication rate from LDC is weakly but negatively corre-
lated with the IF of the journal, the top ten highest rank-
ing journals were analysed, separately. As expected, the
publication rate from LDC markedly dropped to 10.2% in
those journals, which approaches to already published
reports. This finding is consistent with the response of
corresponding authors; an overwhelming majority of
whom believes that it is difficult to publish in high quality
international journals.
In the face of the population size of the LDC, there is a
gross underrepresentation of publications emerging from
these countries. In order to understand the reasons under-
lying this underrepresentation, the corresponding authors
were asked to identify them. Broadly, the reasons identi-
fied by them can be grouped into two categories. First, the
reasons that are associated with the review process of the
journals such as biased attitude and lack of trust among
reviewers and editors on the data generated in their coun-
tries. In the second category, the reasons are associated
with deficiencies prevailing within the scientists from LDC
such as poor writing skills and poor quality of research.
The former reasons were identified as the major hurdles
underlying the non-acceptance of their publications by an
overwhelming majority of authors. Indeed, there are some
reports that have suggested that the data generated in low
income nations is undervalued [25]. Moreover, a statisti-
cally significant difference between the high and low
income countries in terms of rejection rate of submitted
manuscripts has been shown [26].
As far as the improvement in the quality of research in
LDC is concerned, this is mainly linked to the political
system of the country. It is known that research is the
last priority in the majority of LDC with science being
considered by governments as a luxury that can be
afforded only by rich countries [27]. Thus poor funding,
lack of incentives to scientists and resources will even-
tually lead to poor research facilities, limited technical
support and inadequate training. Obviously, with all
these barriers, the scientific activities and research will be
hampered. It is conceivable that under these less-
encouraging circumstances, both quantity and quality of
research would also be affected. Indeed, it has been
shown that the number of submissions from LDC was far
fewer (5.2% of the total submissions) compared to high
income countries in psychiatry journals [19]. As far as
the other reasons identified by the authors are concerned,
Table 4 Reasons underlying difficulties in publications in the opinion of corresponding authors
Reason n (% of respondents) N = 250
Biased attitude of reviewers and editors against authors from developing countries 162 (64.8)
Poor writing skills 132 (52.8)
Reviewers and Editors do not trust data generated in developing countries 100 (40.0)
Quality of research is not good in developing countries 78 (31.2)
Lack of funding and other resources 74 (29.6)
Unimpressive publication record of the authors 42 (16.8)
Lack of generalisibility of results 18 (7.2)
Total responses* 606
*The number of responses (606) exceeds the number of respondents (250) because the majority of respondents selected more than one reasons.
The corresponding authors who thought that publishing from their countries is difficult were asked to identify the reasons underlying the difficulties in
publishing.
Table 5 Attributes that increase the chances of
acceptance for publication in good quality journals
Attribute n (% of respondents)
N = 326
Well-written manuscript 248 (76.1)
Improvement in the quality of research 228 (69.9)
Multidisciplinary research 140 (42.9)
Having collaborator/coauthor from
developed country
120 (36.8)
Sound publication record 86 (26.4)
Total responses* 822
*The number of responses (822) exceeds the number of respondents (326)
because majority of respondents selected more than one attribute.
All corresponding authors from the less-developed countries were asked to
identify the measures that can increases the chances of acceptance of their
manuscript.
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Page 6 of 8if these are valid, they can easily be resolved by the scien-
tific community and the international journals. For exam-
ple, one inherent reason is the poor writing skills of
researchers from LDC because English is not the first
language for the majority of these nations. Influential
international journals with adequate human resources
can come forward and offer a free service for checking
and editing the manuscripts from non-English speaking
scientists once they are accepted for publication. As a
matter of policy, rejection of papers based on the inade-
quate usage of language should not be acceptable. Inter-
national journals can initiate another measure to bridge
this gap between the developed countries and LDC by
reserving some pages for papers from LDC. This reserved
section should publish the best research emanating from
the LDC only. This would have a positive impact on the
enthusiasm of the scientists. One case can be cited to
reinforce this suggestion. The Journal of Pakistan Medi-
cal Association started a reserved section for students in
2004. This fostered an interest towards research among
undergraduate medical students and student research
groups at regional and national levels were made. Publi-
cations of their results as lead authors motivated them to
involve themselves in larger projects. Recently, the
undergraduate medical students have launched their own
journal. Furthermore, notable scientists from the LDC
should be invited to serve on the editorial staff of the
international journals since presently, the majority of edi-
torial board members of international medical journals
are residents of highly developed nations [20,28]. This
step may help eliminate the feeling among authors from
LDC that their findings are not given importance.
One limitation of the study is that the data was gener-
ated from papers published in only one issue of all Phar-
macology journals. It is likely that these data may not be
representative of the overall situation. However, the
inclusion of all the journals in the current study has
yielded a sample size which may be considered as suffi-
ciently representative. Second limitation of the current
study is that division of countries is based on the mem-
bership of OECD. This has put some high income coun-
tries like oil-rich Gulf States into LDC. However, this
has been done purposefully because the academic his-
tory of these countries is rather brief. The third limita-
tion is that Pharmacology related subject terms like
antibacterial drugs, toxicology etc were not taken into
account resulting in many journals that were not
included.
Conclusions
The LDC are underrepresented in publications in Phar-
macology journals. The corresponding authors of the
published articles perceive that biased attitude of the
editors as well as the reviewers of international journals
and the poor writing skills of scientists are the major
factors underlying the non-acceptance of their scientific
work. They also think that the improvement in the writ-
ing skills and quality of research will increase the
chances of acceptance of their works in international
journals.
Appendix I
Q1. You are a
□ Faculty
□ Industry person
□ Trainee
□ Support staff
□ Student
□ Any other (please specify)
Q2. Did you submit the present paper in some other
journal(s) where it was rejected?
□ Yes
□ No
Q3. How many journals?
□ 1
□ 2
□ 3
□ 4
□ More than 4
Q4. How long did it take from drafting of manuscript
to final acceptance (including all the previous rejections
if any)? (months)
Q5. Do you think that it is difficult to publish papers
from your country in journals of high impact factors?
□ Yes
□ No
Q 6 .I fy o u ra n s w e rt oq u e s t i o n5i sy e st h a nw h a td o
you think might be the reason(s) (you can choose more
than one option)?
□ Quality of research is not good
□ Biased attitude of editors and reviewers towards
researchers from developing countries
□ Writing skills of scientists from developing countries
are not good
□ Editors & reviewers do not trust data from develop-
ing countries
□ Lack of generalisibility of results from developing
countries
□ Unimpressive publication record of the authors
□ Lack of funding to cover publication costs in some
journals
□ Any other (please specify)
Q7. What in your opinion will increase the chances of
acceptance in journals of high impact factors (you can
choose more than one option)?
□ Improvement in the quality of research
□ Well written manuscript
□ Multidisciplinary research
Rohra BMC Medical Research Methodology 2011, 11:60
http://www.biomedcentral.com/1471-2288/11/60
Page 7 of 8□ Having co-author from developed country
□ Sound publication record of first or corresponding
author
□ Any other (please specify)
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